Reduced expression of the Connexin26 gene and its aberrant DNA methylation in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine. 2006

Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
Laboratory of Cancer Biology and Bioinformatics, Department of Life Science, Faculty of Science and Engineering, Kinki University, Higashiosaka, Osaka, Japan.

Gap junctions are mediated by intercellular channels that connect adjacent cells and are composed of Connexin (Cx) proteins. A member of the Cx family, Cx26 is considered a potential tumor suppressor in several cancers. The expression of Cx26 gene and its methylation status in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) were investigated. Six-wk-old male Wistar rats were given 2,000 ppm BHP in their drinking water for 12 wk and maintained without further treatment until they were sacrificed at 25 wk. A total of nine lung adenocarcinomas were obtained and total RNA was extracted to assess expression by real-time quantitative reverse transcription (RT)-polymerase chain reaction (PCR). Five out of nine adenocarcinomas showed reduced expression compared with normal lung tissue. We next performed a bisulfite sequence analysis to measure the methylation status of the 5' upstream region of the Cx26 gene in two normal lung tissues and five lung adenocarcinomas that showed reduced expression of Cx26. All five adenocarcinomas were highly methylated in the 5' upstream region, while the two normal lung tissues were unmethylated. This suggests that aberrant methylation of the Cx26 gene may be involved in the development of lung adenocarcinomas induced by BHP in rats.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D000072259 Connexin 26 A gap junction protein encoded by the Gap Junction Beta 2 or GJB2 gene. In the cochlea and epidermis, its hexamers form channels between cells that open to allow cell-to-cell diffusion of small molecules as well as recycling of potassium. Mutations in Connexin 26 are associated with congenital SENSORINEURAL HEARING LOSS. Connexin Cx26,Connexin beta-2,Gap Junction beta-2 protein,beta2 Connexin,26, Connexin,Connexin beta 2,Connexin, beta2,Cx26, Connexin,Gap Junction beta 2 protein,beta-2, Connexin
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017630 Connexins A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions. Connexin,Connexin Complex Proteins,Gap Junction Proteins,Gap Junction Channel Proteins,Gap Junction Protein,Junction Protein, Gap,Junction Proteins, Gap

Related Publications

Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
February 2006, Molecular carcinogenesis,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
February 2008, Molecular carcinogenesis,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
November 2000, Japanese journal of cancer research : Gann,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
October 2000, Japanese journal of cancer research : Gann,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
January 2010, Pathobiology : journal of immunopathology, molecular and cellular biology,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
December 2001, Carcinogenesis,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
October 2007, Molecular carcinogenesis,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
August 2004, Molecular carcinogenesis,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
January 2001, Cancer letters,
Kyoko Shimizu, and Yozo Shimoichi, and Daisei Hinotsume, and Yumi Itsuzaki, and Hiromasa Fujii, and Kanya Honoki, and Toshifumi Tsujiuchi
January 2003, Molecular carcinogenesis,
Copied contents to your clipboard!